NASDAQ:SBRA - Sabra Health Care REIT Stock Price, Forecast & News

Sabra Health Care REIT's stock was trading at $13.34 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, SBRA shares have decreased by 16.0% and is now trading at $11.20. View which stocks have been mosted impacted by Coronavirus.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sabra Health Care REIT in the last year. There are currently 1 sell rating, 3 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Sabra Health Care REIT.

Sabra Health Care REIT is scheduled to release its next quarterly earnings announcement on Wednesday, May 13th 2020. View our earnings forecast for Sabra Health Care REIT.

Sabra Health Care REIT Inc (NASDAQ:SBRA) issued its quarterly earnings results on Monday, February, 24th. The real estate investment trust reported $0.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.45 by $0.25. The real estate investment trust earned $155.76 million during the quarter, compared to the consensus estimate of $150.47 million. Sabra Health Care REIT had a return on equity of 2.11% and a net margin of 10.43%. View Sabra Health Care REIT's earnings history.

Sabra Health Care REIT declared a quarterly dividend on Tuesday, February 4th. Investors of record on Friday, February 14th will be paid a dividend of $0.45 per share on Friday, February 28th. This represents a $1.80 annualized dividend and a yield of 16.07%. The ex-dividend date is Thursday, February 13th. View Sabra Health Care REIT's dividend history.

Sabra Health Care REIT issued an update on its FY 2020 Pre-Market earnings guidance on Monday, February, 24th. The company provided earnings per share (EPS) guidance of 1.70-1.80 for the period.

7 analysts have issued 12 month price objectives for Sabra Health Care REIT's stock. Their forecasts range from $10.50 to $25.00. On average, they anticipate Sabra Health Care REIT's stock price to reach $20.42 in the next year. This suggests a possible upside of 82.3% from the stock's current price. View analysts' price targets for Sabra Health Care REIT.

Media coverage about SBRA stock has been trending very negative this week, InfoTrie Sentiment reports. InfoTrie scores the sentiment of media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Sabra Health Care REIT earned a news impact score of -3.0 on InfoTrie's scale. They also assigned headlines about the real estate investment trust a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near term. View the latest news aboutSabra Health Care REIT.

Some companies that are related to Sabra Health Care REIT include American Tower (AMT), Public Storage (PSA), Welltower (WELL), Weyerhaeuser (WY), HCP (HCP), Extra Space Storage (EXR), Ventas (VTR), Medical Properties Trust (MPW), Host Hotels and Resorts (HST), Omega Healthcare Investors (OHI), CubeSmart (CUBE), Life Storage (LSI), Healthcare Realty Trust (HR), Rayonier (RYN) and National Health Investors (NHI).

Based on aggregate information from My MarketBeat watchlists, some companies that other Sabra Health Care REIT investors own include Omega Healthcare Investors (OHI), AT&T (T), Energy Transfer LP Unit (ET), Verizon Communications (VZ), Medical Properties Trust (MPW), New Residential Investment (NRZ), Realty Income (O), Alibaba Group (BABA), Blackstone Group (BX) and Enterprise Products Partners (EPD).

Sabra Health Care REIT trades on the NASDAQ under the ticker symbol "SBRA."

Sabra Health Care REIT's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Cohen & Steers Inc. (6.02%), Principal Financial Group Inc. (4.03%), State Street Corp (3.92%), FMR LLC (3.40%), Bank of New York Mellon Corp (2.42%) and LSV Asset Management (1.90%). Company insiders that own Sabra Health Care REIT stock include Michael J Foster, Raymond J Lewis and Richard K Matros. View institutional ownership trends for Sabra Health Care REIT.

SBRA stock was sold by a variety of institutional investors in the last quarter, including Cohen & Steers Inc., Russell Investments Group Ltd., State Street Corp, Sei Investments Co., Bank of America Corp DE, Westpac Banking Corp, Gateway Investment Advisers LLC, and First Trust Advisors LP. Company insiders that have sold Sabra Health Care REIT company stock in the last year include Michael J Foster, Raymond J Lewis, and Richard K Matros. View insider buying and selling activity for Sabra Health Care REIT.

SBRA stock was acquired by a variety of institutional investors in the last quarter, including Norges Bank, Bank of New York Mellon Corp, Prudential Financial Inc., Nuveen Asset Management LLC, Renaissance Technologies LLC, Marshall Wace North America L.P., Presima Inc., and Goldman Sachs Group Inc.. View insider buying and selling activity for Sabra Health Care REIT.

Shares of SBRA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of SBRA stock can currently be purchased for approximately $11.20.

Sabra Health Care REIT has a market capitalization of $2.30 billion and generates $661.74 million in revenue each year. The real estate investment trust earns $69 million in net income (profit) each year or $1.86 on an earnings per share basis. Sabra Health Care REIT employs 31 workers across the globe. View additional information about Sabra Health Care REIT.

The official website for Sabra Health Care REIT is http://www.sabrahealth.com/.

Sabra Health Care REIT's mailing address is 18500 VON KARMAN AVENUE SUITE 550, IRVINE CA, 92612. The real estate investment trust can be reached via phone at 888-393-8248 or via email at [email protected]